Apimeds Pharmaceuticals US (APUS) vs Enveric Biosciences (ENVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Apimeds Pharmaceuticals US is the larger company by market cap ($7.6 million vs $6.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | ENVB |
|---|---|---|
| Share price | $5.02 | $1.45 |
| Market cap | $7.58M | $6.49M |
| 1-day change | -8.89% | -4.61% |
| YTD return | -66.40% | — |
| 1-year return | -70.53% | — |
| EPS (TTM) | $-36.03 | $-13.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $13.25 |
| 52-week low | $1.51 | $1.17 |
| Distance from 52-week high | -91.59% | -89.06% |
| Average volume | 3.67M | 102.84K |
| Shares outstanding | 1.51M | 4.48M |
| Employees | — | 5 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations
About Enveric Biosciences
ENVB stock →Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
APUS vs ENVB FAQ
Which is bigger, Apimeds Pharmaceuticals US or Enveric Biosciences?
Apimeds Pharmaceuticals US (APUS) is larger, with a market capitalization of $7.58M compared with $6.49M for Enveric Biosciences (ENVB).
Are Apimeds Pharmaceuticals US and Enveric Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.